# US 2017/0281348 A1 · Cancellous Bone Product Including Viable Osteogenic Cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0281348 A1
- Document ID: US20170281348A1
- Status: Published application
- Kind: A1
- Application number: 15/622,985
- Filed: 2017-06-14
- Published: 2017-10-05
- Earliest claimed: 2006-05-08
- Assignees: NuVasive, Inc.
- Applicants: NuVasive, Inc
- Inventors: Michelle LeRoux Williams; Charles Randal Mills; Rodney Monroy; Robert A. Zambon; Dayna Buskirk; Earl Fender
- Web page: https://patentgrep.com/patent/US20170281348A1

## CPC

- A61L 27/365: {Bones}
- A61L 27/3608: {Bone, e.g. demineralised bone matrix [DBM], bone powder}
- A61L 27/3687: {characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents}
- A61F 2/28: Bones
- A61F 2310/00359: Bone or bony tissue
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

A bone implant comprising cancellous bone that is essentially free of blood cells, and which has been treated with at least one loosening agent, such as collagenase or a digestive enzyme, for a time and at a concentration to loosen the osteogenic cells in the cancellous bone matrix. The osteogenic cells in the matrix are viable cells. The treatment of the cancellous bone with at least one loosening agent enables the osteogenic cells to be more available for carrying out their osteogenic function and to provide for an increased rate of bone formation. Such implant also may include demineralized bone, such as demineralized cortical bone, which enhances the bone regenerative capacity of the cancellous bone.

## Claims

### Claim 1

A bone implant, comprising:
cancellous bone, said cancellous bone being essentially free of blood cells and having been treated with at least one loosening agent for a time and at a concentration to loosen osteogenic cells in the cancellous bone matrix, said osteogenic cells in the cancellous bone matrix being viable cells.

### Claim 2 (depends on 1)

The implant of claim 1 wherein said at least one loosening agent is selected from the group consisting of collagenase and digestive enzymes.

### Claim 3 (depends on 2)

The implant of claim 2 wherein said at least one loosening agent is collagenase.

### Claim 4 (depends on 3)

The implant of claim 3 wherein said bone is treated with said collagenase at a concentration of from about 0.1 mg/ml to about 3 mg/ml.

### Claim 5 (depends on 4)

The implant of claim 4 wherein said bone is treated with said collagenase at a concentration of from about 1.0 mg/ml to about 3 mg/ml.

### Claim 6 (depends on 3)

The implant of claim 3 wherein said bone is treated with said collagenase for a period of time from about 5 min. to about 3 hrs.

### Claim 7 (depends on 6)

The implant of claim 6 wherein said bone is treated with said collagenase for a period of time from about 5 min. to about 30 min.

### Claim 8 (depends on 3)

The implant of claim 3 wherein said bone is treated with said collagenase at a concentration of about 1.0 mg/ml for a period of time from about 10 minutes.

### Claim 9

A bone implant comprising:
(i) cancellous bone, said cancellous bone including cancellous bone which is essentially free of blood cells and having been treated with at least one loosening agent for a time and at a concentration to loosen osteogenic cells in the cancellous bone matrix, said osteogenic cells in the cancellous bone matrix being viable cells; and
(ii) cortical bone which has been treated with at least one demineralization agent for a time and at a concentration to expose osteoinductive proteins present in the cortical bone matrix.

### Claim 10 (depends on 9)

The implant of claim 9 wherein said at least one demineralization agent is hydrochloric acid.

### Claim 11 (depends on 10)

The implant of claim 10 wherein said cortical bone is treated with said hydrochloric acid at a concentration of from about 0.1N to about 12N.

### Claim 12 (depends on 11)

The implant of claim 11 wherein said cortical bone is treated with said hydrochloric acid at a concentration of about 0.5N.

### Claim 13 (depends on 9)

The implant of claim 9 wherein said cortical bone is treated with said at least one demineralization agent for a period of time of from about 1 minute to about 72 hours.

### Claim 14 (depends on 13)

The implant of claim 13 wherein said cortical bone is treated with said at least one demineralization agent for a period of time of from about 50 minutes to about 70 minutes.

### Claim 15 (depends on 9)

The implant of claim 9 wherein said cortical bone comprises particles having a D90 of less than about 1,500 microns.

### Claim 16 (depends on 15)

The implant of claim 15 wherein said particles have a D90 from about 125 microns to about 1,500 microns.

### Claim 17 (depends on 16)

The implant of claim 16 wherein said particles have a D90 from about 780 microns to about 1,500 microns.

### Claim 18 (depends on 16)

The implant of claim 16 wherein said particles have a D90 from about 125 microns to about 780 microns.

### Claim 19 (depends on 15)

The implant of claim 15 wherein said cortical bone comprises a first portion comprising particles having a D90 of from about 780 microns to about 1,500 microns and a second portion comprising particles having a D90 of from about 125 microns to about 780 microns.

### Claim 20 (depends on 19)

The bone implant of claim 19 wherein said bone implant includes at least 50 vol. % of said cancellous bone, from about 5 vol. % to about 40 vol. % of said cortical bone particles having a D90 of from about 780 microns to about 1,500 microns, and from about 5 vol. % to about 20 vol. % of said cortical bone particles having a D90 of from about 125 microns to about 780 microns.

### Claim 21 (depends on 20)

The implant of claim 20 wherein said cancellous bone is present in said implant in an amount of from about 55 vol. % to about 85 vol. %.

### Claim 22 (depends on 20)

The implant of claim 20 wherein said cortical bone particles having a D90 from about 125 microns to about 780 microns are present in an amount of from about 8 vol. % to about 18 vol. %.
